KEGG    Network variation - Acute myeloid leukemia
[ Network menu | Network entry | Help ]
ENTRYnt06275
NameAcute myeloid leukemia
CategoryDisease view; Cancer
Pathwayhsa05221 Acute myeloid leukemia
DiseaseH00003 Acute myeloid leukemia
Display drug-target relation   disease type
ERK signaling
   D1
 |
            
N00215    KITLGKITGRB2SOSRASRAFMEKERK
N00003      KIT*GRB2SOSRASRAFMEKERK
N00217    FLT3LGFLT3GRB2SOSRASRAFMEKERK
   D1,D2
 |
            
N00004      FLT3*GRB2SOSRASRAFMEKERK
N00012            (KRAS*,NRAS*)RAFMEKERKCCND1
PI3K signaling
   D1
 |
          
N00045    KITLGKITPI3KPIP3AKTMTORS6K
N00046      KIT*PI3KPIP3AKTBAD
N00218    FLT3LGFLT3GRB2SOSRASPI3KPIP3AKTMTOR
   D1,D2
 |
              
N00031      FLT3*GRB2SOSRASPI3KPIP3AKTBAD
N00032            (KRAS*,NRAS*)PI3KPIP3AKTBAD
JAK-STAT signaling
N00219    FLT3LGFLT3STAT5
   D1,D2
 |
    
N00054      FLT3*STAT5PIM1/2
Transcription
N00116    RUNX1*(CSF1R,MPO,CSF2,IL..
N00111    AML1-ETOCEBPAPER2
N00112    AML1-ETOSPI1(CD14,ITGAM,FCGR1A..
N00108    AML1-ETOJUP
N00109    PML-RARA(JUP,CCNA1)
N00113    PML-RARA(CEBPE,BCL2A1)
N00110    PLZF-RARA(JUP,CCNA1,MYC)
N00114    PLZF-RARADUSP6


Drug name
D1D05029Midostaurin (JAN/USAN/INN)
D2D10800Gilteritinib fumarate (JAN/USAN)